Home
About
Overview
Sharing Data
ORCID
Help
History (7)
High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the University of Chicago experience.
Insurance Benefits
Insurance, Liability
Vasoconstrictor Agents
Growing evidence for 'time to sign'.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Growing evidence for 'time to sign'.
Growing evidence for 'time to sign'. Patient Educ Couns. 2013 Dec; 93(3):667.
View in:
PubMed
subject areas
Educational Status
Female
Health Literacy
Humans
Male
authors with profiles
Stacy Lindau